Senior insider sale
Chief Executive Officer at UNITY BIOTECHNOLOGY, INC. — senior position signals high conviction
$14.5K
5.40K shares
What this filing means
GHOSH ANIRVAN plans to sell 5.40K shares of UNITY BIOTECHNOLOGY, INC. valued at approximately $14.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/14/2023ACC: 0000950170-23-028071
DirectorOfficer· Chief Executive Officer
Since Mar 2020
5.40K
Shares to sell
$14.5K
Approx. market value
1.21K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units granted in 2020 under the Issuer's 2018 Incentive Award Plan
NA
6/13/2023
1.21KTotal acquired1.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/13/2023 | Restricted Stock Units granted in 2020 under the Issuer's 2018 Incentive Award Plan NA | 1.21K | — |
| Total | 1.21K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.02K
Market value
$2.2K
5/1/2023
—Completed
Units to sell
1.96K
Market value
$3.3K
3/31/2023
—Completed
Units to sell
1.21K
Market value
$4.8K
3/14/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.21K
Market value
$4.1K
6/14/2023
Total
Units
5.40K
Value
$14.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2023 | 1.02K | $2.2K | — | Completed |
3/31/2023 | 1.96K | $3.3K | — | Completed |
3/14/2023 | 1.21K | $4.8K | — | Completed |
| Planned — Approximate Date | ||||
6/14/2023 | 1.21K | $4.1K | NASDAQ | Planned |
| Total | 5.40K | $14.5K | ||